Loading…
CIK 0001855655 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("paradigm-biocapital-advisors-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $191.2M | 4.9%Prev: 3.8% | 1,417,473 SH | Increased-146,723 SH |
| APOGEE THERAPEUTICS INC | COM | $84.8M | 2.2%Prev: 1.7% | 1,123,243 SH | Increased-398,514 SH |
| ARCELLX INC | COMMON STOCK | $373.2M | 9.5%Prev: 10.9% | 5,724,016 SH | Decreased+1,075,000 SH |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $22.6M | 0.6% | 665,251 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $28.3M | 0.7%Prev: 0.6% | 2,261,749 SH | Increased+395,608 SH |
| BRIDGEBIO PHARMA INC | COM | $52.3M | 1.3%Prev: 1.0% | 684,277 SH | Increased |
| CIDARA THERAPEUTICS INC | COM NEW | $167.8M | 4.3%Prev: 2.6% | 759,565 SH | Increased-201,599 SH |
| CRINETICS PHARMACEUTICALS IN | COM | $102.9M | 2.6%Prev: 3.0% | 2,210,774 SH | Decreased-340,000 SH |
| EDGEWISE THERAPEUTICS INC | COM | $162.3M | 4.1%Prev: 2.8% | 6,541,210 SH | Increased+371,079 SH |
| ERASCA INC | COM | $52.7M | 1.3%Prev: 0.8% | 14,159,095 SH | Increased+599,078 SH |
| EYEPOINT INC | COM NEW | $67.4M | 1.7% | 3,691,475 SH | New |
| GENMAB A/S | SPONSORED ADS | $216.8M | 5.5%Prev: 3.3% | 7,039,834 SH | Increased+3,222,983 SH |
| INVENTIVA SA | ADS | $18.6M | 0.5% | 4,000,000 SH | New |
| KALARIS THERAPEUTICS INC | COM | $5.9M | 0.2% | 700,000 SH | New |
| LEXEO THERAPEUTICS INC | COM | $47.3M | 1.2% | 4,763,198 SH | New |
| NUVALENT INC | COM | $530.1M | 13.5%Prev: 13.0% | 5,269,433 SH | Increased |
| OCULAR THERAPEUTIX INC | COM | $35.6M | 0.9%Prev: 1.2% | 2,935,284 SH | Decreased-562,023 SH |
| OLEMA PHARMACEUTICALS INC | COM | $188.6M | 4.8%Prev: 1.9% | 7,544,172 SH | Increased+750,000 SH |
| ORIC PHARMACEUTICALS INC | COM | $19.6M | 0.5% | 2,401,217 SH | New |
| ORUKA THERAPEUTICS INC | COM | $51.8M | 1.3% | 1,710,316 SH | New |
| REVOLUTION MEDICINES INC | COM | $529.2M | 13.5%Prev: 8.3% | 6,644,403 SH | Increased+421,112 SH |
| SCHOLAR ROCK HLDG CORP | COM | $134.9M | 3.4%Prev: 2.1% | 3,062,157 SH | Increased+1,052,412 SH |
| SPDR SERIES TRUST | STATE STREET SPD | $182.9M | 4.7% | 1,500,000 SH | New |
| SPYRE THERAPEUTICS INC | COM NEW | $48.1M | 1.2%Prev: 0.7% | 1,467,266 SH | Increased |
| TARSUS PHARMACEUTICALS INC | COM | $209.8M | 5.4%Prev: 4.5% | 2,562,154 SH | Increased-103,544 SH |
| TERNS PHARMACEUTICALS INC | COM | $32.7M | 0.8% | 810,286 SH | New |
| UROGEN PHARMA LTD | COM | $104.8M | 2.7%Prev: 2.4% | 4,473,648 SH | Increased+257,564 SH |
| VAXCYTE INC | COM | $187.7M | 4.8%Prev: 3.9% | 4,068,020 SH | Increased+283,265 SH |
| VIRIDIAN THERAPEUTICS INC | COM | $44.9M | 1.1%Prev: 1.6% | 1,443,102 SH | Decreased-1,166,251 SH |
| VOR BIOPHARMA INC | COM NEW | $22.9M | 0.6% | 1,750,000 SH | New |
| 13F-HR |
| 0001855655-26-000014 |
| $5.34B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001855655-25-000010 | $2.34B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001855655-26-000011 | $4.89B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001855655-25-000007 | $2.18B | View |